JP2018513117A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2018513117A5 JP2018513117A5 JP2017546870A JP2017546870A JP2018513117A5 JP 2018513117 A5 JP2018513117 A5 JP 2018513117A5 JP 2017546870 A JP2017546870 A JP 2017546870A JP 2017546870 A JP2017546870 A JP 2017546870A JP 2018513117 A5 JP2018513117 A5 JP 2018513117A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- formulated
- dexamethasone
- corneal
- kit
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| NZ705727 | 2015-03-05 | ||
| NZ70572715 | 2015-03-05 | ||
| PCT/NZ2016/050033 WO2016140581A1 (en) | 2015-03-05 | 2016-03-04 | Ophthalmic compositions and methods of use therefor |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021011148A Division JP2021091688A (ja) | 2015-03-05 | 2021-01-27 | 眼科用組成物およびその使用方法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2018513117A JP2018513117A (ja) | 2018-05-24 |
| JP2018513117A5 true JP2018513117A5 (https=) | 2019-04-11 |
Family
ID=56848288
Family Applications (4)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017546870A Pending JP2018513117A (ja) | 2015-03-05 | 2016-03-04 | 眼科用組成物およびその使用方法 |
| JP2021011148A Pending JP2021091688A (ja) | 2015-03-05 | 2021-01-27 | 眼科用組成物およびその使用方法 |
| JP2023030945A Active JP7641650B2 (ja) | 2015-03-05 | 2023-03-01 | 眼科用組成物およびその使用方法 |
| JP2024218517A Pending JP2025032318A (ja) | 2015-03-05 | 2024-12-13 | 眼科用組成物およびその使用方法 |
Family Applications After (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021011148A Pending JP2021091688A (ja) | 2015-03-05 | 2021-01-27 | 眼科用組成物およびその使用方法 |
| JP2023030945A Active JP7641650B2 (ja) | 2015-03-05 | 2023-03-01 | 眼科用組成物およびその使用方法 |
| JP2024218517A Pending JP2025032318A (ja) | 2015-03-05 | 2024-12-13 | 眼科用組成物およびその使用方法 |
Country Status (11)
| Country | Link |
|---|---|
| US (2) | US10842850B2 (https=) |
| EP (1) | EP3265096B9 (https=) |
| JP (4) | JP2018513117A (https=) |
| KR (1) | KR102450674B1 (https=) |
| CN (1) | CN107530360B (https=) |
| AU (1) | AU2016226699B2 (https=) |
| ES (1) | ES2952700T3 (https=) |
| MY (1) | MY186271A (https=) |
| SG (1) | SG11201708114SA (https=) |
| TW (1) | TWI747816B (https=) |
| WO (1) | WO2016140581A1 (https=) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9622911B2 (en) | 2010-09-30 | 2017-04-18 | Cxl Ophthalmics, Llc | Ophthalmic treatment device, system, and method of use |
| EP2830627B1 (en) | 2012-03-29 | 2024-05-01 | Epion Therapeutics, Inc. | Ocular treatment solutions, delivery devices and delivery augmentation methods |
| ES2986057T3 (es) | 2012-03-29 | 2024-11-08 | Epion Therapeutics Inc | Composiciones y métodos para tratar o prevenir enfermedades asociadas al estrés oxidativo |
| TWI747816B (zh) | 2015-03-05 | 2021-12-01 | 紐西蘭商奧克蘭聯合服務有限公司 | 眼用組合物用於製備藥物的用途 |
| KR102706856B1 (ko) | 2015-07-21 | 2024-09-19 | 아베드로 인코퍼레이티드 | 광증감제로 눈을 치료하기 위한 시스템 및 방법 |
| CN110092816B (zh) * | 2018-01-29 | 2023-08-01 | 上海市第一人民医院 | 预防和治疗纤维化的小分子多肽及其应用 |
| US20210060017A1 (en) * | 2018-02-27 | 2021-03-04 | Shilpa Medicare Ltd | Methotrexate ophthalmic solution |
| CN108728418A (zh) * | 2018-06-19 | 2018-11-02 | 新乡医学院 | 一种鸡胚中枢神经系统单个神经元动态研究模型的制备方法及应用 |
| WO2020092897A1 (en) * | 2018-11-02 | 2020-05-07 | Senseonics, Incorporated | Drug eluting matrix on analyte indicator |
| GB201820021D0 (en) * | 2018-12-07 | 2019-01-23 | Univ Birmingham | Ocular hydrogel compositions |
| JP2022125941A (ja) * | 2021-02-17 | 2022-08-29 | 株式会社ティ・エム・ディ | コンタクトレンズ |
| JP2025529178A (ja) | 2022-09-01 | 2025-09-04 | オプティファイ・セラピューティクス・アクティエンゲゼルシャフト | 眼科用組成物 |
| EP4687950A1 (en) * | 2023-03-30 | 2026-02-11 | Cetel Scientific LLC | Amniotic and chorionic collagen for ocular surface healing |
Family Cites Families (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3786812A (en) * | 1972-03-10 | 1974-01-22 | C Neefe | Contact lens for olar drug delivery |
| US4177268A (en) | 1973-05-30 | 1979-12-04 | Jouveinal S.A. | Method of alleviating inflammation by administration of dexamethasone derivatives |
| US5124392A (en) * | 1988-10-03 | 1992-06-23 | Alcon Laboratories, Inc. | Pharmaceutical compositions and methods of treatment to prevent and treat corneal scar formation produced by laser irradiation |
| AU660635B2 (en) * | 1990-11-16 | 1995-07-06 | Celtrix Pharmaceuticals, Inc. | A beta-type transforming growth factor |
| US5411940A (en) | 1993-09-29 | 1995-05-02 | Alcon Laboratories, Inc. | Use of TGF-β3 to reduce the formation of scar tissue in response to corneal trauma |
| CN1770976A (zh) | 2003-02-13 | 2006-05-10 | 人类起源公司 | 利用脐带血治疗患有疾病、紊乱或状况的个体的用途 |
| MXPA03011987A (es) | 2003-12-19 | 2005-06-23 | Osio Sancho Alberto | Metodo para el tratamiento de la presbicia induciendo cambios en el poder y fisiologia corneal. |
| WO2007099337A1 (en) | 2006-03-01 | 2007-09-07 | Cartela R&D Ab | Expansion and differentiation of mesenchymal stem cells |
| GB0604938D0 (en) | 2006-03-11 | 2006-04-19 | Renovo Ltd | Proteins, nucleic acids and medicaments |
| US7767217B2 (en) | 2006-03-14 | 2010-08-03 | Foresight Biotherapeutics | Ophthalmic compositions comprising povidone-iodine |
| US8110655B2 (en) | 2006-11-13 | 2012-02-07 | Auxagen, Inc. | Method to promote hair growth and/or delay or treat hair loss by administering a TGF-β antagonist or inhibitor |
| AU2007319811A1 (en) | 2006-11-15 | 2008-05-22 | Coda Therapeutics, Inc. | Improved methods and compositions for wound healing |
| JP2011505409A (ja) | 2007-12-04 | 2011-02-24 | ノバガリ ファーマ エスエー | パルミチン酸デキサメタゾンのようなコルチコステロイドプロドラッグを含有する眼障害の治療用の組成物 |
| US7795316B1 (en) | 2007-12-19 | 2010-09-14 | Alcon Research, Ltd. | Topical ophthalmic compositions containing tobramycin and dexamethasone |
| EP2249921B1 (en) | 2008-02-25 | 2020-06-17 | Eyegate Pharmaceuticals, Inc. | Enhanced delivery of dexamethasone phosphate to ocular tissues through iontophoresis |
| EP2370054B1 (en) * | 2008-12-11 | 2015-10-07 | Massachusetts Institute of Technology | Contact lens drug delivery device |
| US10201548B2 (en) | 2009-03-06 | 2019-02-12 | Sun Pharma Global Fze | Methods for treating ocular inflammatory diseases |
| WO2012088044A2 (en) | 2010-12-20 | 2012-06-28 | James Mcmillan | Compositions and methods for improving ocular surface health, corneal clarity, optical function and maintaining visual acuity |
| US20130165419A1 (en) * | 2011-12-21 | 2013-06-27 | Insite Vision Incorporated | Combination anti-inflammatory ophthalmic compositions |
| KR101518370B1 (ko) | 2013-06-25 | 2015-05-07 | 가톨릭대학교 산학협력단 | Il-10 생성 조절 t세포로의 분화 유도용 조성물 |
| CN104548210A (zh) | 2014-12-13 | 2015-04-29 | 浙江大学 | 含地塞米松转化生长因子的可控缓释plga微球及制备 |
| TWI747816B (zh) | 2015-03-05 | 2021-12-01 | 紐西蘭商奧克蘭聯合服務有限公司 | 眼用組合物用於製備藥物的用途 |
| US10537585B2 (en) | 2017-12-18 | 2020-01-21 | Dexcel Pharma Technologies Ltd. | Compositions comprising dexamethasone |
-
2016
- 2016-03-04 TW TW105106605A patent/TWI747816B/zh active
- 2016-03-04 WO PCT/NZ2016/050033 patent/WO2016140581A1/en not_active Ceased
- 2016-03-04 US US15/555,909 patent/US10842850B2/en active Active
- 2016-03-04 SG SG11201708114SA patent/SG11201708114SA/en unknown
- 2016-03-04 KR KR1020177028161A patent/KR102450674B1/ko active Active
- 2016-03-04 ES ES16759200T patent/ES2952700T3/es active Active
- 2016-03-04 AU AU2016226699A patent/AU2016226699B2/en active Active
- 2016-03-04 MY MYPI2017703238A patent/MY186271A/en unknown
- 2016-03-04 CN CN201680026065.0A patent/CN107530360B/zh active Active
- 2016-03-04 EP EP16759200.5A patent/EP3265096B9/en active Active
- 2016-03-04 JP JP2017546870A patent/JP2018513117A/ja active Pending
-
2020
- 2020-10-23 US US17/078,949 patent/US11938168B2/en active Active
-
2021
- 2021-01-27 JP JP2021011148A patent/JP2021091688A/ja active Pending
-
2023
- 2023-03-01 JP JP2023030945A patent/JP7641650B2/ja active Active
-
2024
- 2024-12-13 JP JP2024218517A patent/JP2025032318A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2018513117A5 (https=) | ||
| Kim et al. | Laser in situ keratomileusis versus laser-assisted subepithelial keratectomy for the correction of high myopia | |
| Miranda et al. | Ferrara intrastromal corneal ring segments for severe keratoconus | |
| Lee et al. | Epithelial healing and clinical outcomes in excimer laser photorefractive surgery following three epithelial removal techniques: mechanical, alcohol, and excimer laser | |
| Coscarelli et al. | Intrastromal corneal ring segment implantation to correct astigmatism after penetrating keratoplasty | |
| Zhang et al. | A review of collagen cross‐linking in cornea and sclera | |
| Pellegrini et al. | Outcomes of cataract surgery with toric intraocular lens implantation after keratoplasty | |
| Paysse et al. | Pediatric refractive surgery: corneal and intraocular techniques and beyond | |
| Althomali | Posterior chamber toric phakic IOL implantation for the management of pediatric anisometropic amblyopia | |
| Kramer et al. | Scleral lenses in the treatment of post-LASIK ectasia and superficial neovascularization of intrastromal corneal ring segments | |
| El-Agha et al. | Comparison of photorefractive keratectomy and laser in situ keratomileusis for the treatment of compound hyperopic astigmatism | |
| Manns et al. | Use of corneal cross-linking beyond keratoconus: a systemic literature review | |
| Lane et al. | Prophylactic use of mitomycin-C in the management of a buttonholed LASIK flap | |
| Eissa et al. | ICL versus SMILE in management of anisometropic myopic amblyopia in children | |
| de Benito-Llopis et al. | Comparison between LASEK and LASIK for the correction of low myopia | |
| Kim et al. | Full-thickness astigmatic keratotomy combined with small-incision lenticule extraction to treat high-level and mixed astigmatism | |
| Stahl | Pediatric refractive surgery | |
| Durrie et al. | Secondary intraocular lens implantation vs epikeratophakia for the treatment of aphakia | |
| El-Khoury et al. | Under‐the‐flap crosslinking and LASIK in early ectasia with hyperopic refractive error | |
| Hafez | Comparison of epithelium-off and transepithelial corneal collagen cross-linking for treatment of keratoconus | |
| Chen et al. | Management of complex epithelial ingrowth after laser in situ keratomileusis using fibrin tissue glue | |
| Magli et al. | Photorefractive keratectomy for myopic anisometropia: a retrospective study on 18 children | |
| Jankov et al. | Lenticular intrastromal keratoplasty for keratoconus | |
| RU2816066C1 (ru) | Способ лечения повреждений роговичного лоскута микрокератомом в процессе кераторефракционной операции LASIK или Femtolasik | |
| Sánchez-González et al. | Permavision intracorneal inlay after sixteen years. Regression of initial refractive hyperopia |